tm logo

Monitor this mark

View On USPTO

NEUCYTE
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 07 Mar 2024

Last Applicant/ Owned by

Neucyte, Inc.

319 N Bernardo Ave,

Mountain View

CA

94043

Serial Number

87126222 filed on 03rd Aug 2016

Registration Number

5318216 registered on 24th Oct 2017

in the Principal Register

Correspondent Address

Kathryn Starshak

Kathryn Starshak K&L Gates LLP

Chicago, IL 60690-1135

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

NEUCYTE

Pharmaceutical drug identification and development services; pharmaceutical drug development services in the field of neurological disorders

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Pharmaceutical drug identification and development services; pharmaceutical drug development services in the field of neurological disorders

First Use Date in General

02th Nov 2015

First Use Date in Commerce

02th Nov 2015

Mark Details

Serial Number

No 87126222

Mark Type

No Service Mark

Attorney Docket Number

No 1106950-002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
07th Mar 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07th Mar 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07th Mar 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15th Sep 2023TEAS SECTION 8 & 15 RECEIVED
24th Oct 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
24th Oct 2017REGISTERED-PRINCIPAL REGISTER
21st Sep 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
20th Sep 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05th Sep 2017STATEMENT OF USE PROCESSING COMPLETE
02th Sep 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL